ARTICLE | Clinical News
Bexsero regulatory update
August 19, 2013 7:00 AM UTC
Novartis said Australia's Therapeutic Goods Administration ( TGA) approved Bexsero to vaccinate against meningococcal disease in individuals aged >=2 months. Novartis plans to launch the multi-compone...